Intellia Therapeutics, Inc. ($NTLA)
Filing Information
| Accession Number | 0001193125-26-088260 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
113,120
Total Value
$16,687.58
P&L
+inf% (+$1,467,126.99)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, General Counsel | Common Stock | โ | Mar 1, 2026 | Grant/Award | 46,080 | $0.00 | $0.00 | 158,005 | Direct | โ | View Details | |
EVP, General Counsel | Common Stock | โ | Mar 2, 2026 | Sale | 1,211 | $13.78 | $16,687.58 | 156,794 | Direct | โ | View Details | |
EVP, General Counsel | Stock Option (right to buy) | Derivative | Mar 1, 2026 | Grant/Award | 65,829 | $0.00 | $0.00 | 65,829 | Direct | โ | View Details |